A prospective, single-arm evaluating the efficacy and safety of chidamide, CAG and DLI in patients with high risk or relapse hematological malignancies after allogeneic stem cell transplantation.
Phase of Trial: Phase II
Latest Information Update: 20 Aug 2018
At a glance
- Drugs Aclarubicin (Primary) ; Cytarabine (Primary) ; Tucidinostat (Primary)
- Indications Haematological malignancies
- Focus Therapeutic Use
- 20 Aug 2018 New trial record